⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9266325 | 1.00 | — | — | |
| SCHEMBL2686685 | 1.00 | — | — | |
| SCHEMBL9269730 | 1.00 | — | — | |
| SCHEMBL9265710 | 1.00 | — | — | |
| SCHEMBL9692177 | 0.81 | SMN1; SMN2 (0.48) | — | |
| SCHEMBL432483 | 0.77 | — | — | |
| SCHEMBL374192 | 0.77 | — | — | |
| SCHEMBL35509 | 0.77 | — | — | |
| SCHEMBL31261231 | 0.77 | SMN1; SMN2 (0.54) | — | |
| SCHEMBL31261230 | 0.77 | SMN1; SMN2 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180078518-A1 | Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing Cardiovascular Disease | GLAS AMERICAS LLC | 2018-03-22 | — | — | US | disclosed |
| WO-2017079755-A1 | GEMCABENE COMBINATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE | GEMPHIRE THERAPEUTICS INC. (US) | 2017-05-11 | — | — | WO | disclosed |
| WO-2009056539-A1 | FERMENTATIVE PRODUCTION OF SIMVASTATIN | DSM IP ASSETS B.V. (NL) | 2009-05-07 | — | — | WO | disclosed |
| US-20070048351-A1 | Drugs coated on a device to treat vulnerable plaque | PRESCIENT MEDICAL, INC. (US) | 2007-03-01 | — | — | US | disclosed |
| WO-2005044258-A1 | SIMVASTATIN FORMULATIONS AND METHODS OF MAKING SAME | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2005-05-19 | — | — | WO | disclosed |